MagnetisMM-3: Long-term update and outcomes of less frequent dosing of elranatamab in relapsed/refractory multiple myeloma Meeting Abstract


Authors: Searle, E.; Prince, H. M.; Bahlis, N.; Rodriguez-Otero, P.; Karlin, L.; Akard, L.; Varshavsky-Yanovsky, A.; Nagai, Y.; Vesole, D.; Chu, M.; Hickman, A.; Sullivan, S.; Leip, E.; Conte, U.; Viqueira, A.; Lesokhin, A.
Abstract Title: MagnetisMM-3: Long-term update and outcomes of less frequent dosing of elranatamab in relapsed/refractory multiple myeloma
Meeting Title: 65th Annual Scientific Meeting of the British Society for Haematology (BSH)
Journal Title: British Journal of Haematology
Volume: 206
Issue: Suppl. 1
Meeting Dates: 2025 Apr 27-29
Meeting Location: Glasgow, Scotland
ISSN: 0007-1048
Publisher: John Wiley & Sons  
Date Published: 2025-04-01
Language: English
ACCESSION: WOS:001517858300048
PROVIDER: wos
DOI: 10.1111/bjh.20117
Notes: Meeting Abstract: PO67 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Meyer Lesokhin
    381 Lesokhin